Trial intelligence / Profile preview

Pilot study of perioperative vitamins E and C and/or omega-3 fatty acids to reduce reperfusion injury after cardiac surgery

2006-003011-46Phase 2Completed

Sponsor
Dr. Olaf Stanger
Start
Aug 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 2 trial of vitamin e, ascorbic acid and omega-3 fatty acid in coronary arteriosclerosis, sponsored by Dr. Olaf Stanger. Primary endpoint: Primary endpoint (pilot study). Started Aug 2006; status: completed.

02

Drugs

vitamin eascorbic acidomega-3 fatty acid
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2006-003011-46.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003011-46.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call